Blog
EQT Gears Up to Report Q4 Earnings: What's in the Cards?
EQT Corporation EQT is set to report fourth-quarter 2025 results on Feb. 17, 2026, after the closing bell.
In the last reported quarter, the natural gas producer reported earnings of 52 cents per
South Korea ETF (EWY) Hits New 52-Week High
iShares MSCI South Korea ETF EWY is probably on the radar for investors seeking momentum. The fund just hit a 52-week high and moved up 169.60% from its 52-week low price of $48.49 per share.
Are
U's Q4 Earnings & Revenues Surpass Estimates, Both Increase Y/Y
Unity Software U reported fourth quarter 2025 non-GAAP earnings per share (EPS) of 24 cents compared to a loss of 30 cents in the year-ago quarter and beat the Zacks Consensus Estimate by 20%. The
U's Q4 Earnings & Revenues Surpass Estimates, Both Increase Y/Y
Unity Software U reported fourth quarter 2025 non-GAAP earnings per share (EPS) of 24 cents compared to a loss of 30 cents in the year-ago quarter and beat the Zacks Consensus Estimate by 20%. The
AVTR Stock Plunges Despite Q4 Earnings Beat Estimates, Margins Decline
Avantor, Inc. AVTR reported fourth-quarter 2025 adjusted earnings per share (EPS) of 22 cents, down 18.5% from the year-ago quarter. However, the bottom line surpassed the Zacks Consensus Estimate
Franklin Resources & Binance Unveil New Institutional Collateral Plan
Franklin Resources, Inc. BEN and Binance announced the launch of a new off-exchange institutional collateral program, aiming to make digital asset trading safer and more capital-efficient. The
Franklin Resources & Binance Unveil New Institutional Collateral Plan
Franklin Resources, Inc. BEN and Binance announced the launch of a new off-exchange institutional collateral program, aiming to make digital asset trading safer and more capital-efficient. The
AVTR Stock Plunges Despite Q4 Earnings Beat Estimates, Margins Decline
Avantor, Inc. AVTR reported fourth-quarter 2025 adjusted earnings per share (EPS) of 22 cents, down 18.5% from the year-ago quarter. However, the bottom line surpassed the Zacks Consensus Estimate
MDGL Strengthens MASH Franchise With New Genetic Approaches
Madrigal Pharmaceuticals MDGL announced an exclusive global licensing agreement with Suzhou Ribo Life Science Co. Ltd. (Ribo) and its subsidiary, Ribocure Pharmaceuticals AB (Ribocure), covering six
MDGL Strengthens MASH Franchise With New Genetic Approaches
Madrigal Pharmaceuticals MDGL announced an exclusive global licensing agreement with Suzhou Ribo Life Science Co. Ltd. (Ribo) and its subsidiary, Ribocure Pharmaceuticals AB (Ribocure), covering six
RNR Boosts Dividend, Expands Buyback in Shareholder-Friendly Push
Global insurer RenaissanceRe Holdings Ltd. RNR recently announced a 2.5% or 1 cent hike in its quarterly dividend payout. In its latest shareholder-friendly move, RNR raised its quarterly dividend
RNR Boosts Dividend, Expands Buyback in Shareholder-Friendly Push
Global insurer RenaissanceRe Holdings Ltd. RNR recently announced a 2.5% or 1 cent hike in its quarterly dividend payout. In its latest shareholder-friendly move, RNR raised its quarterly dividend
IRWD Rises 307% in 6 Months: Is This an Indication to Buy the Stock?
Shares of Ironwood Pharmaceuticals IRWD have risen sharply over the past six months, primarily driven by the improving demand for its sole marketed product, Linzess (linaclotide) and the company’s
Will Heavy Capex Spending Weigh on Alibaba's AI Ambitions?
Alibaba Group BABA is doubling down on artificial intelligence, but the financial toll of its aggressive spending spree is raising uncomfortable questions about near-term profitability. The company
Will Heavy Capex Spending Weigh on Alibaba's AI Ambitions?
Alibaba Group BABA is doubling down on artificial intelligence, but the financial toll of its aggressive spending spree is raising uncomfortable questions about near-term profitability. The company
Vertiv Q4 Earnings Beat Estimates, Net Sales Up Y/Y, Shares Fall
Vertiv Holdings VRT reported fourth-quarter 2025 non-GAAP earnings of $1.36 per share, beating the Zacks Consensus Estimate by 5.80%. The figure jumped 37.4% year over year.Net sales increased 22.7%
Vertiv Q4 Earnings Beat Estimates, Net Sales Up Y/Y, Shares Fall
Vertiv Holdings VRT reported fourth-quarter 2025 non-GAAP earnings of $1.36 per share, beating the Zacks Consensus Estimate by 5.80%. The figure jumped 37.4% year over year.Net sales increased 22.7%
Organon (OGN) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
For the quarter ended December 2025, Organon (OGN) reported revenue of $1.51 billion, down 5.3% over the same period last year. EPS came in at $0.63, compared to $0.90 in the year-ago quarter.
The
Organon (OGN) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
For the quarter ended December 2025, Organon (OGN) reported revenue of $1.51 billion, down 5.3% over the same period last year. EPS came in at $0.63, compared to $0.90 in the year-ago quarter.
The
Bruker (BRKR) Reports Q4 Earnings: What Key Metrics Have to Say
For the quarter ended December 2025, Bruker (BRKR) reported revenue of $977.2 million, down 0.2% over the same period last year. EPS came in at $0.59, compared to $0.76 in the year-ago quarter.
The
Crocs (CROX) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
Crocs (CROX) reported $957.64 million in revenue for the quarter ended December 2025, representing a year-over-year decline of 3.3%. EPS of $2.29 for the same period compares to $2.52 a year ago.
Zoetis Stock Gains After Q4 Earnings & Revenues Beat Estimates
Zoetis, Inc. ZTS delivered fourth-quarter 2025 adjusted earnings (excluding one-time items) of $1.48 per share, which surpassed the Zacks Consensus Estimate of $1.40. In the year-ago quarter, the
Can Jabil's Consumer Electronics Expertise Boost Future Profits?
Jabil Inc. JBL is focused on strengthening its footprint in the consumer electronics market by expanding its advanced manufacturing capabilities and enhancing partnerships with leading global



